リコンビナントタンパク質＿精製したリコンビナントタンパク質 » CD25/IL-2Rα, hFc, Human
CD25/IL-2Rα Fc Chimera, Human

Immobilized IL-2,Human (Cat.No.Z03074) at 5μg/mL (100 μL/well) can bind CD25/IL-2Rα, Fc Chimera,Human with a linear range of 1.2-11 ng/mL.

CD25/IL-2Rα Fc Chimera, Human

The IL-2 receptor system consists of three non-covalently linked subunits termed IL-2Rα, IL-2Rβ, and IL-2Rγ. The IL-2Rα is a type I transmembrane protein consisting of a 219 amino acid (a.a.) extracellular domain, a 19 a.a. transmembrane domain and a 13 a.a. intracellular domain, which is not involved in the transduction of IL-2 signal. Activated T cells, regulatory T cells (Tregs) and NK cells express high levels of CD25 and expression of the high-affinity IL-2Rα is mostly limited to these cell populations. Signaling via IL-2Rα mediates multiple biological processes in various cell populations, e.g. proliferation and differentiation of B cells and NK cells. A soluble form of IL-2Rα (IL-2Rα) appears in serum, concomitant with its increased expression on cells. The function of the soluble IL-2Rα is unclear. Increased levels of IL-2Rα in biological fluids reportedly correlate with increased T and B cell activation and immune system activation. Increased serum concentration of IL-2Rα has been observed in patients with a variety of inflammatory conditions and in the course of some leukemias and lymphomas.
Z03400
¥21,750.00

Ask us a question
Product Introduction
Species Human
Protein Construction
CD25/IL-2Rα (Glu22-Cys213)
Accession # P01589		 hFc
N-term C-term
Purity > 95% as analyzed by SDS-PAGE
Endotoxin Level < 0.2 EU/μg of protein by gel clotting method
Biological Activity Immobilized Human IL-2 at 5.0 μg/ml (100 µl/well) can bind CD25/IL-2Rα, hFc, Human.
Expression System HEK 293
Apparent Molecular Weight 65~75 kDa, on SDS-PAGE under reducing conditions.
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.

Examples
  • CD25/IL-2Rα Fc Chimera, Human
    • CD25/IL-2Rα Fc Chimera, Human

    Immobilized IL-2,Human (Cat.No.Z03074) at 5μg/mL (100 μL/well) can bind CD25/IL-2Rα, Fc Chimera,Human with a linear range of 1.2-11 ng/mL.


Background
Target Background The IL-2 receptor system consists of three non-covalently linked subunits termed IL-2Rα, IL-2Rβ, and IL-2Rγ. The IL-2Rα is a type I transmembrane protein consisting of a 219 amino acid (a.a.) extracellular domain, a 19 a.a. transmembrane domain and a 13 a.a. intracellular domain, which is not involved in the transduction of IL-2 signal. Activated T cells, regulatory T cells (Tregs) and NK cells express high levels of CD25 and expression of the high-affinity IL-2Rα is mostly limited to these cell populations. Signaling via IL-2Rα mediates multiple biological processes in various cell populations, e.g. proliferation and differentiation of B cells and NK cells. A soluble form of IL-2Rα (IL-2Rα) appears in serum, concomitant with its increased expression on cells. The function of the soluble IL-2Rα is unclear. Increased levels of IL-2Rα in biological fluids reportedly correlate with increased T and B cell activation and immune system activation. Increased serum concentration of IL-2Rα has been observed in patients with a variety of inflammatory conditions and in the course of some leukemias and lymphomas.
Synonyms CD25 antigen; CD25; IDDM10; IL-2 R alpha; IL-2Rα

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.